HIGHLIGHTS
- who: Antonella Turla from the Medical Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, ASST Spedali Civili, Brescia, Italy have published the paper: Supportive therapies in patients with advanced adrenocortical carcinoma submitted to standard EDP-M regimen, in the Journal: (JOURNAL)
- what: EDP-M is an aggressive chemotherapy scheme burdened with significant toxicity.
SUMMARY
EDP-M (etoposide, doxorubicin, cisplatin combined with mitotane) is the standard first-line regimen in the management of patients with advanced adrenocortical carcinoma (ACC), an extremely rare disease. The . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.